サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1454093

抗腫瘍薬市場：タイプ別、疾患タイプ別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024-2032年

Anti-Neoplastic Agents Market, By Type, By Disease Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 299 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.95円
抗腫瘍薬市場：タイプ別、疾患タイプ別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024-2032年
出版日: 2024年03月11日
発行: AnalystView Market Insights
ページ情報: 英文 299 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

抗腫瘍薬市場規模は2023年に1,247億1,000万米ドルとなり、2024年から2032年にかけてCAGR 8.5％で拡大

抗腫瘍薬市場- 市場力学

がん患者数の増加が市場成長を促進すると予測

高齢化、ライフスタイルの変化、がんリスク要因へのさらなる曝露など、さまざまな要因により、がんの有病率は世界的に増加しています。米国疾病管理予防センターによると、2020年に米国で新たに報告されたがんの症例数は160万3,844件で、この病気に起因する死亡者数は60万2,347人です。これは10万人当たり403人が新たにがんに罹患し、144人が死亡する計算になります。世界のがん患者数の増加に伴い、抗腫瘍薬を含む、より多様で効果的な治療選択肢に対するニーズが高まっています。このような需要は、これらの薬剤の市場拡大に直接寄与しています。さらに、創薬・薬剤開発技術の進歩は、市場のさらなる成長機会をもたらしています。しかし、薬剤開発コストの高さが市場成長の制約となる可能性があります。

抗腫瘍薬市場-主要インサイト

弊社リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約8.5%のCAGRで毎年成長すると予測されます。

タイプ別セグメンテーションでは、化学療法薬が2023年に最大市場シェアを示すと予測されています。

用途別では、2023年に病院が主要なタイプでした。

地域別では、アジア太平洋地域が2023年の売上をリードしています。

抗腫瘍薬市場-セグメンテーション分析：

世界の抗腫瘍薬市場は、タイプ、疾患タイプ、用途、地域に基づいてセグメント化されます。

市場はタイプ別に3つに分類される：生物学的製剤、個別化医療、化学療法薬、その他です。化学療法薬が市場をリード化学療法薬は抗腫瘍薬市場のかなりの部分を占めており、がん治療に携わる製薬企業の収益に大きく貢献しています。

市場は疾患タイプによって3つのグループに分類される：消化器がん、前立腺がん、肺がん、乳がん、その他です。抗腫瘍薬市場は、がんの種類によって治療法や治療薬が異なるため、疾患タイプによって異なります。

市場は用途によって4つのセグメントに分類される：病院、診療所、がんリハビリテーションセンター、外来手術センターです。病院は、がん治療の中心的な拠点として機能しているため、市場で支配的な地位を占めています。患者は病院で、手術、化学療法、放射線療法、標的療法、免疫療法など、包括的な治療を受けます。

抗腫瘍薬市場-地理的洞察

市場は地理的に北米、ラテンアメリカ、アジア太平洋、中東・アフリカに広がっており、各地域はさらに国別に区分されています。革新的な治療法を開発するために製薬会社が多額の研究開発投資を行っていることから、アジア太平洋地域が市場の成長をリードすると予測されます。アジア太平洋地域の製薬企業は、より効率的で標的を絞ったがん治療法の発見を目指し、新たな抗腫瘍薬を生み出すための大規模な研究開発に注力しています。特に中国は、イノベーション能力を高める努力の一環として、2022年に過去最高の3兆900億元（4,430億米ドル）を研究開発に割り当て、前年比10.4％増を記録しました。国家統計局によると、2022年の中国の研究開発費はGDPの2.55％を占め、前年比で0.12ポイント上昇しました。欧州は、血液および血液関連疾患の増加により、予測期間中2番目に大きな市場地域になると予想されます。

抗腫瘍薬市場-競合情勢：

抗腫瘍薬市場の競合情勢は、効率的ながん治療に対するニーズの高まり、世界のがん罹患率の増加、治療薬の絶え間ない技術革新に牽引され、熾烈を極めています。強力な研究開発能力を持ち、医薬品開発に成功した歴史を持つ企業が、画期的な治療法の導入において優位に立つ可能性が高いです。競合は、抗腫瘍薬を患者に効率的に届けるための市場参入と流通戦術を中心に展開されます。これには、流通業者、薬局、病院、医療専門家と協力関係を結び、製品の入手可能性と市場へのリーチを最適化することが含まれます。

目次

第1章 抗腫瘍薬市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 抗腫瘍薬の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 抗腫瘍薬業界の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 抗腫瘍薬市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 抗腫瘍薬市場情勢

  • 抗腫瘍薬市場シェア分析、2023年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 抗腫瘍薬市場- タイプ別

  • 概要
    • タイプ別、セグメントシェア分析
    • 生物学的製剤
    • 個別化医療
    • 化学療法薬
    • その他

第8章 抗腫瘍薬市場- 疾患タイプ別

  • 概要
    • 疾患タイプ別、セグメントシェア分析
    • 消化器がん
    • 前立腺がん
    • 肺がん
    • 乳がん
    • その他

第9章 抗腫瘍薬市場- 用途別

  • 概要
    • 用途別、セグメントシェア分析
    • 病院
    • クリニック
    • がんリハビリテーションセンター
    • 外来手術センター

第10章 抗腫瘍薬市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東とアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 抗腫瘍薬業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Pfizer Inc
    • Merck &Co.
    • Bayer AG
    • Bristul-Myers Squibb Company
    • Amgen Inc.
    • Boehringer Ingelheim GmbH
    • F. Hoffmann-La Roche Ltd
    • Novartis
    • Celgene Corporation
    • Aspen Holdings
    • Baxter Healthcare Corporation
    • Teva pharmaceutical Industries Ltd
    • Takeda
    • Genentech Inc.
    • Others

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Anti-Neoplastic Agents Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Anti-Neoplastic Agents Market, by Type 2019-2032 (USD Million)
  • TABLE Anti-Neoplastic Agents Market: Disease Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Type
  • TABLE Global Anti-Neoplastic Agents Market, by Disease Type 2019-2032 (USD Million)
  • TABLE Anti-Neoplastic Agents Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Anti-Neoplastic Agents Market, by Application 2019-2032 (USD Million)
  • TABLE Anti-Neoplastic Agents Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Anti-Neoplastic Agents Market, by Region 2019-2032 (USD Million)
  • TABLE North America Anti-Neoplastic Agents Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Anti-Neoplastic Agents Market, by Type, 2019-2032 (USD Million)
  • TABLE North America Anti-Neoplastic Agents Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE North America Anti-Neoplastic Agents Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Anti-Neoplastic Agents Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Anti-Neoplastic Agents Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe Anti-Neoplastic Agents Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Europe Anti-Neoplastic Agents Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Anti-Neoplastic Agents Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Anti-Neoplastic Agents Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Anti-Neoplastic Agents Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Anti-Neoplastic Agents Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Anti-Neoplastic Agents Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Anti-Neoplastic Agents Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America Anti-Neoplastic Agents Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Latin America Anti-Neoplastic Agents Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Anti-Neoplastic Agents Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Anti-Neoplastic Agents Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Anti-Neoplastic Agents Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Anti-Neoplastic Agents Market, by Application, 2019-2032 (USD Million)

List of Figures

  • FIGURE Anti-Neoplastic Agents Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Type segment market share analysis, 2023 & 2032
  • FIGURE Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Disease Type segment market share analysis, 2023 & 2032
  • FIGURE Disease Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Anti-Neoplastic Agents Market share and leading players, 2023
  • FIGURE Europe Anti-Neoplastic Agents Market share and leading players, 2023
  • FIGURE Asia Pacific Anti-Neoplastic Agents Market share and leading players, 2023
  • FIGURE Latin America Anti-Neoplastic Agents Market share and leading players, 2023
  • FIGURE Middle East and Africa Anti-Neoplastic Agents Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Anti-Neoplastic Agents Market share analysis by country, 2023
  • FIGURE Germany Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Anti-Neoplastic Agents Market share analysis by country, 2023
  • FIGURE India Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Anti-Neoplastic Agents Market share analysis by country, 2023
  • FIGURE Brazil Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Anti-Neoplastic Agents Market share analysis by country, 2023
  • FIGURE Saudi Arabia Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Anti-Neoplastic Agents Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV2274

REPORT HIGHLIGHT

Anti-Neoplastic Agents Market size was valued at USD 124,710 Million in 2023, expanding at a CAGR of 8.5% from 2024 to 2032.

Antineoplastic agents, also known as anticancer drugs, make up a broad and varied category of medications. They are a key component of chemotherapy, targeting and eliminating mutated human cells. Despite their specific focus on abnormal cells, these drugs can also impact healthy cells. Their mechanisms of action may involve influencing cell survival or enhancing the immune system's ability to fight off irregular cells. Workers in healthcare settings, including pharmacists, pharmacy technicians, physicians, nurses, and even housekeeping staff, may face potential exposure to antineoplastic agents while handling and administering these medications, as well as disposing of contaminated waste materials.

Anti-Neoplastic Agents Market- Market Dynamics

Growing cancer Patient Population is anticipated to propel the market growth

The prevalence of cancer is increasing worldwide due to various factors such as the aging population, changes in lifestyle, and greater exposure to cancer risk factors. According to the Center for Disease Control and Prevention, there were 1,603,844 new cases of cancer reported in the United States in 2020, with 602,347 deaths attributed to the disease. This translates to 403 new cases and 144 deaths per 100,000 individuals. With the rising number of cancer patients globally, there is a growing need for more diverse and effective treatment options, including anti-neoplastic agents. This demand directly contributes to the expansion of the market for these drugs. Additionally, advancements in technology for drug discovery and development present opportunities for further growth in the market. However, the high cost of drug development may pose a constraint on market growth.

Anti-Neoplastic Agents Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.5% over the forecast period (2024-2032)

Based on Type segmentation, Chemotherapeutic Agents was predicted to show maximum market share in the year 2023

Based on Application segmentation, Hospitals was the leading type in 2023

On the basis of region, Asia pacific was the leading revenue generator in 2023

Anti-Neoplastic Agents Market- Segmentation Analysis:

The Global Anti-Neoplastic Agents Market is segmented on the basis of Type, Disease Type, Application, and Region.

The market is segmented into three categories according to Type: Biological Agents, Personalized Medicine, Chemotherapeutic Agents, and Others. Chemotherapeutic Agents lead the market. Chemotherapeutic agents make up a considerable portion of the anti-neoplastic agents market, contributing significantly to the revenue generated by pharmaceutical companies involved in cancer therapeutics.

The market is categorized into three groups according to the disease type: Gastrointestinal Cancer, Prostate Cancer, Lung Cancer, Breast Cancer, and Others. The market for anti-neoplastic agents differs depending on the disease type, as each type of cancer necessitates distinct treatment methods and therapeutic agents.

The market is categorized into four segments according to its application: Hospitals, Clinics, Cancer Rehabilitation Centers, and Ambulatory Surgical Centers. Hospitals hold a dominant position in the market as they act as central hubs for cancer treatment. Patients receive a comprehensive range of therapies at hospitals, including surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy.

Anti-Neoplastic Agents Market- Geographical Insights

The market is geographically spread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa, with each region further segmented by countries. Asia Pacific is projected to lead the market growth, thanks to significant R&D investments made by pharmaceutical companies to develop innovative therapies. Pharmaceutical companies in Asia Pacific are focusing on extensive research and development to create new anti-neoplastic agents, aiming to discover more efficient and targeted treatments for cancer. China, in particular, allocated a record 3.09 trillion yuan (USD443 billion) for research and development in 2022, marking a 10.4 percent increase from the previous year as part of its efforts to boost innovation capabilities. According to the National Bureau of Statistics, China's R&D spending represented 2.55 percent of the GDP in 2022, a 0.12 percentage point rise compared to the previous year. Europe is anticipated to be the second largest market region during the forecast period, driven by the increasing prevalence of blood and blood-related disorders.

Anti-Neoplastic Agents Market- Competitive Landscape:

The competitive landscape in the anti-neoplastic agents market is fierce, driven by the increasing need for efficient cancer treatments, the global burden of cancer, and the constant innovation in therapeutic agents. Companies with strong research and development capabilities and a history of successful drug development are likely to have a competitive edge in introducing groundbreaking therapies. Competition revolves around market access and distribution tactics to guarantee the efficient delivery of anti-neoplastic agents to patients. This involves forming collaborations with distributors, pharmacies, hospitals, and healthcare professionals to optimize product availability and market reach.

Recent Developments:

In December 2023, Pfizer Inc. and Seagen Inc. have recently reached a definitive merger agreement, with Pfizer acquiring Seagen, a renowned global biotechnology company specializing in the development and commercialization of groundbreaking cancer medicines. The acquisition will be made at a price of USD229 in cash per Seagen share, resulting in a total enterprise value of USD43 billion.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANTI-NEOPLASTIC AGENTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Pfizer Inc

Merck & Co.

Bayer AG

Bristul-Myers Squibb Company

Amgen Inc.

Boehringer Ingelheim GmbH

F. Hoffmann-La Roche Ltd

Novartis

Celgene Corporation

Aspen Holdings

Baxter Healthcare Corporation

Teva pharmaceutical Industries Ltd

Takeda

Genentech Inc.

Others

GLOBAL ANTI-NEOPLASTIC AGENTS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Biological Agents
  • Personalized Medicine
  • Chemotherapeutic Agents
  • Others

GLOBAL ANTI-NEOPLASTIC AGENTS MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Gastrointestinal Cancer
  • Prostate Cancer
  • Lung Cancer
  • Breast Cancer
  • Others

GLOBAL ANTI-NEOPLASTIC AGENTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Cancer Rehabilitation Centers
  • Ambulatory Surgical Centers

GLOBAL ANTI-NEOPLASTIC AGENTS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Anti-Neoplastic Agents Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Anti-Neoplastic Agents Market Snippet by Type
    • 2.1.2.Anti-Neoplastic Agents Market Snippet by Disease Type
    • 2.1.3.Anti-Neoplastic Agents Market Snippet by Application
    • 2.1.4.Anti-Neoplastic Agents Market Snippet by Country
    • 2.1.5.Anti-Neoplastic Agents Market Snippet by Region
  • 2.2.Competitive Insights

3.Anti-Neoplastic Agents Key Market Trends

  • 3.1.Anti-Neoplastic Agents Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Anti-Neoplastic Agents Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Anti-Neoplastic Agents Market Opportunities
  • 3.4.Anti-Neoplastic Agents Market Future Trends

4.Anti-Neoplastic Agents Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Anti-Neoplastic Agents Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Anti-Neoplastic Agents Market Landscape

  • 6.1.Anti-Neoplastic Agents Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Anti-Neoplastic Agents Market - By Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2.Biological Agents
    • 7.1.3.Personalized Medicine
    • 7.1.4.Chemotherapeutic Agents
    • 7.1.5.Others

8.Anti-Neoplastic Agents Market - By Disease Type

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Disease Type, 2023 & 2032 (%)
    • 8.1.2.Gastrointestinal Cancer
    • 8.1.3.Prostate Cancer
    • 8.1.4.Lung Cancer
    • 8.1.5.Breast Cancer
    • 8.1.6.Others

9.Anti-Neoplastic Agents Market - By Application

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2.Hospitals
    • 9.1.3.Clinics
    • 9.1.4.Cancer Rehabilitation Centers
    • 9.1.5.Ambulatory Surgical Centers

10.Anti-Neoplastic Agents Market- By Geography

  • 10.1.Introduction
    • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2.North America
    • 10.2.1.Overview
    • 10.2.2.Anti-Neoplastic Agents Key Manufacturers in North America
    • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4.North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5.North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.2.6.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7.U.S.
      • 10.2.7.1.Overview
      • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3.U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4.U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8.Canada
      • 10.2.8.1.Overview
      • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3.Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4.Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.Europe
    • 10.3.1.Overview
    • 10.3.2.Anti-Neoplastic Agents Key Manufacturers in Europe
    • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4.Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5.Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.6.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7.Germany
      • 10.3.7.1.Overview
      • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3.Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4.Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8.Italy
      • 10.3.8.1.Overview
      • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3.Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4.Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9.United Kingdom
      • 10.3.9.1.Overview
      • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3.United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4.United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10.France
      • 10.3.10.1.Overview
      • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3.France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4.France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11.Russia
      • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2.Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3.Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12.Netherlands
      • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2.Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3.Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13.Sweden
      • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2.Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3.Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14.Poland
      • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2.Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3.Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15.Rest of Europe
      • 10.3.15.1.Overview
      • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.Asia Pacific (APAC)
    • 10.4.1.Overview
    • 10.4.2.Anti-Neoplastic Agents Key Manufacturers in Asia Pacific
    • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4.Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5.Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.6.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7.India
      • 10.4.7.1.Overview
      • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3.India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4.India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8.China
      • 10.4.8.1.Overview
      • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3.China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4.China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9.Japan
      • 10.4.9.1.Overview
      • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3.Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4.Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10.South Korea
      • 10.4.10.1.Overview
      • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3.South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4.South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11.Australia
      • 10.4.11.1.Overview
      • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3.Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4.Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12.Thailand
      • 10.4.12.1.Overview
      • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3.Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4.Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13.Indonesia
      • 10.4.13.1.Overview
      • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3.Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4.Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14.Philippines
      • 10.4.14.1.Overview
      • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3.Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4.Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15.Rest of APAC
      • 10.4.15.1.Overview
      • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3.Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4.Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.Latin America
    • 10.5.1.Overview
    • 10.5.2.Anti-Neoplastic Agents Key Manufacturers in Latin America
    • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4.Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5.Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.6.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7.Brazil
      • 10.5.7.1.Overview
      • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3.Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4.Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8.Mexico
      • 10.5.8.1.Overview
      • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3.Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4.Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9.Argentina
      • 10.5.9.1.Overview
      • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3.Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4.Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10.Colombia
      • 10.5.10.1.Overview
      • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3.Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4.Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11.Rest of LATAM
      • 10.5.11.1.Overview
      • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.Middle East and Africa
    • 10.6.1.Overview
    • 10.6.2.Anti-Neoplastic Agents Key Manufacturers in Middle East and Africa
    • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4.Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5.Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.6.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7.Saudi Arabia
      • 10.6.7.1.Overview
      • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8.United Arab Emirates
      • 10.6.8.1.Overview
      • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9.Israel
      • 10.6.9.1.Overview
      • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3.Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4.Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10.Turkey
      • 10.6.10.1.Overview
      • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3.Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4.Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11.Algeria
      • 10.6.11.1.Overview
      • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3.Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4.Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12.Egypt
      • 10.6.12.1.Overview
      • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3.Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4.Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13.Rest of MEA
      • 10.6.13.1.Overview
      • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3.Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4.Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Anti-Neoplastic Agents Industry

  • 11.1.Competitive Dashboard
  • 11.2.Company Profiles
    • 11.2.1.Pfizer Inc
    • 11.2.2.Merck & Co.
    • 11.2.3.Bayer AG
    • 11.2.4.Bristul-Myers Squibb Company
    • 11.2.5.Amgen Inc.
    • 11.2.6.Boehringer Ingelheim GmbH
    • 11.2.7.F. Hoffmann-La Roche Ltd
    • 11.2.8.Novartis
    • 11.2.9.Celgene Corporation
    • 11.2.10.Aspen Holdings
    • 11.2.11.Baxter Healthcare Corporation
    • 11.2.12.Teva pharmaceutical Industries Ltd
    • 11.2.13.Takeda
    • 11.2.14.Genentech Inc.
    • 11.2.15.Others

12.360 Degree Analyst View

13.Appendix

  • 13.1.Research Methodology
  • 13.2.References
  • 13.3.Abbreviations
  • 13.4.Disclaimer
  • 13.5.Contact Us